Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-09-007160
Filing Date
2009-03-16
Accepted
2009-03-16 16:44:01
Documents
9
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 REXAHN PARMACEUTICAL INC 10-K 12-31-2008 form10-k.htm 10-K 1801438
2 EXHIBIT 14 ex14.htm EX-13 29382
3 EXHIBIT 23.1 ex23_1.htm EX-23.1 2991
4 EXHIBIT 23.2 ex23_2.htm EX-23.2 2843
5 EXHIBIT 24 ex24.htm EX-24 40739
6 EXHIBIT 31.1 ex31_1.htm EX-31.1 16614
7 EXHIBIT 31.2 ex31_2.htm EX-31.2 15485
8 EXHIBIT 32.1 ex32_1.htm EX-32.1 11517
9 EXHIBIT 32.2 ex32_2.htm EX-32.2 10163
  Complete submission text file 0001140361-09-007160.txt   1932681
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Filer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-34079 | Film No.: 09684929
SIC: 2834 Pharmaceutical Preparations